Showing 321 - 340 results of 8,742 for search '"genetic engineering"', query time: 0.23s Refine Results
  1. 321

    Developing a genetic engineering method for Acetobacterium wieringae to expand one-carbon valorization pathways by João P. C. Moreira, John T. Heap, Joana I. Alves, Lucília Domingues

    Published 2023-02-01
    “…The species A. wieringae has not been genetically modified, therefore developing a genetic engineering method is important for expanding its product portfolio from gas fermentation and overall improving the characteristics of this acetogen for industrial demands. …”
    Get full text
    Article
  2. 322

    Brain-Wide Transgene Expression in Mice by Systemic Injection of Genetically Engineered Exosomes: CAP-Exosomes by Saumyendra N. Sarkar, Deborah Corbin, James W. Simpkins

    Published 2024-02-01
    “…In this manuscript, we describe, for the first time, the development of a workflow to generate a novel brain-targeted drug delivery system that involves the generation of genetically engineered exosomes by first selecting various functional AAV capsid-specific peptides (collectively called CAPs) known to be involved in brain-targeted high-expression gene delivery, and then expressing the CAPs in frame with lysosome-associated membrane glycoprotein (Lamp2b) followed by expressing CAP-Lamp2b fusion protein on the surface of mesenchymal stem cell-derived exosomes, thus generating CAP-exosomes. …”
    Get full text
    Article
  3. 323
  4. 324
  5. 325

    Genetically engineered mouse models of cancer reveal new insights about the antitumor immune response by DuPage, Michel J., Jacks, Tyler E.

    Published 2016
    “…Cells of the immune system are critical components of this extrinsic network of cancer regulators, contributing significantly to the microenvironment of most cancers and either promoting or inhibiting the initiation and progression of this disease. Genetically engineered mouse (GEM) mouse models of spontaneous cancer are starting to shape our understanding of how antitumor T cells may act to prevent or inhibit cancer progression in some settings and not others. …”
    Get full text
    Get full text
    Article
  6. 326
  7. 327

    Genetically Engineered Alginate Lyase-PEG Conjugates Exhibit Enhanced Catalytic Function and Reduced Immunoreactivity by Lamppa, John W., Ackerman, Margaret E., Lai, Jennifer I., Scanlon, Thomas C., Griswold, Karl E.

    Published 2011
    “…To effectively deimmunize one therapeutic candidate while maintaining high level catalytic proficiency, a combined genetic engineering-PEGylation strategy was implemented. …”
    Get full text
    Article
  8. 328

    A Candida albicans CRISPR system permits genetic engineering of essential genes and gene families by Vyas, Valmik K., Barrasa, M. Inmaculada, Fink, Gerald R

    Published 2015
    “…The lack of meiosis coupled with the absence of plasmids makes genetic engineering cumbersome, especially for essential functions and gene families. …”
    Get full text
    Get full text
    Article
  9. 329
  10. 330
  11. 331

    Genetically engineered metal ion binding sites on the outside of a Channel's transmembrane beta-barrel. by Kasianowicz, J, Burden, D, Han, L, Cheley, S, Bayley, H

    Published 1999
    “…We are exploring the ability of genetically engineered versions of the Staphylococcus aureus alpha-hemolysin (alphaHL) ion channel to serve as rationally designed sensor components for analytes including divalent cations. …”
    Journal article
  12. 332
  13. 333
  14. 334
  15. 335
  16. 336
  17. 337
  18. 338

    Genetically engineered IgG1 and nanobody oligomers acquire strong intrinsic CD40 agonism by Nienke Hesen, Mohamed Anany, Andre Freidel, Mediya Baker, Daniela Siegmund, Olena Zaitseva, Harald Wajant, Isabell Lang

    Published 2024-12-01
    “…We proved here the hypothesis that oligomeric and oligovalent anti-CD40 antibody variants generated by genetic engineering display high intrinsic, thus FcγR-independent, agonistic activity. …”
    Get full text
    Article
  19. 339
  20. 340

    Giant cell arteritis. Part III. New trends in its treatment (role of genetically engineered drugs) by Azamat Makhmudovich Satybaldyev

    Published 2013-03-01
    “…The evidence supporting the use of methotrexate, as well as genetically engineered agents (GEAs), infliximab, etanercept) as steroid-sparing agents is discussed. …”
    Get full text
    Article